Ai G, Wu X, Dou Y, Huang R, Zhong L, Liu Y, Xian Y, Lin Z, Li Y, Su Z, Chen J, Qu C (2022) Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway. Food Chem Toxicol 166:113215. https://doi.org/10.1016/j.fct.2022.113215

Article  CAS  PubMed  Google Scholar 

Aron-Wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, Nieuwdorp M, Clément K (2020) Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol 17:279–297. https://doi.org/10.1038/s41575-020-0269-9

Article  PubMed  Google Scholar 

Arroyave-Ospina JC, Wu Z, Geng Y, Moshage H (2021) Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy. Antioxid. https://doi.org/10.3390/antiox10020174

Article  Google Scholar 

Azevedo Tosta TA, de Faria PR, Neves LA, do Nascimento MZ (2019) Computational normalization of H&E-stained histological images: progress, challenges and future potential. Artif Intell Med 95:118–132. https://doi.org/10.1016/j.artmed.2018.10.004

Article  PubMed  Google Scholar 

Bao Y, Han X, Liu D, Tan Z, Deng Y (2022) Gut microbiota: the key to the treatment of metabolic syndrome in traditional Chinese medicine - a case study of diabetes and nonalcoholic fatty liver disease. Front Immunol 13:1072376. https://doi.org/10.3389/fimmu.2022.1072376

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cariello M, Piccinin E, Moschetta A (2021) Transcriptional regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH. Cell Mol Gastroenterol Hepatol 11:1519–1539. https://doi.org/10.1016/j.jcmgh.2021.01.012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chambers ES, Morrison DJ, Frost G (2015) Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms? Proc Nutr Soc 74:328–336. https://doi.org/10.1017/s0029665114001657

Article  CAS  PubMed  Google Scholar 

Chen J, Deng X, Liu Y, Tan Q, Huang G, Che Q, Guo J, Su Z (2020) Kupffer cells in non-alcoholic fatty liver disease: friend or foe? Int J Biol Sci 16:2367–2378. https://doi.org/10.7150/ijbs.47143

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Sun Y, Zhao H, Qi X, Cui H, Li Q, Ma Y (2022) α-Lactalbumin peptide asp-gln-trp alleviates hepatic insulin resistance and modulates gut microbiota dysbiosis in high-fat diet-induced NAFLD mice. Food Funct 13:9878–9892. https://doi.org/10.1039/d2fo01343f

Article  CAS  PubMed  Google Scholar 

Chen L, Lei Y, Lu C, Liu D, Ma W, Lu H, Wang Y (2024) Punicic acid ameliorates obesity-related hyperlipidemia and fatty liver in mice via regulation of intestinal flora and lipopolysaccharide-related signaling pathways. Food Funct 15:5012–5025. https://doi.org/10.1039/d4fo00502c

Article  CAS  PubMed  Google Scholar 

Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960–967. https://doi.org/10.1111/j.1572-0241.2003.07486.x

Article  CAS  PubMed  Google Scholar 

Cui K, Zhang L, La X, Wu H, Yang R, Li H, Li Z (2022) Ferulic acid and P-Coumaric acid synergistically attenuate non-alcoholic fatty liver disease through HDAC1/PPARG-mediated free fatty acid uptake. Int J Mol Sci. https://doi.org/10.3390/ijms232315297

Article  PubMed  PubMed Central  Google Scholar 

Dai X, Jiang K, Ma X, Hu H, Mo X, Huang K, Jiang Q, Chen Y, Liu C (2024) Mendelian randomization suggests a causal relationship between gut microbiota and nonalcoholic fatty liver disease in humans. Med 103:e37478. https://doi.org/10.1097/md.0000000000037478

Article  CAS  Google Scholar 

de Vries M, Westerink J, Kaasjager K, de Valk HW (2020) Prevalence of nonalcoholic fatty liver Disease (NAFLD) in patients with type 1 diabetes Mellitus: a systematic review and Meta-analysis. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa575

Article  PubMed  PubMed Central  Google Scholar 

Ding Y, Yanagi K, Yang F, Callaway E, Cheng C, Hensel ME, Menon R, Alaniz RC, Lee K, Jayaraman A (2024) Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice. Elife. https://doi.org/10.7554/eLife.87458

Article  PubMed  PubMed Central  Google Scholar 

Fang C, Pan J, Qu N, Lei Y, Han J, Zhang J, Han D (2022) The AMPK pathway in fatty liver disease. Front Physiol 13:970292. https://doi.org/10.3389/fphys.2022.970292

Article  PubMed  PubMed Central  Google Scholar 

Francque S, Szabo G, Abdelmalek MF, Byrne CD, Cusi K, Dufour JF, Roden M, Sacks F, Tacke F (2021) Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. Nat Rev Gastroenterol Hepatol 18:24–39. https://doi.org/10.1038/s41575-020-00366-5

Article  PubMed  Google Scholar 

Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908–922. https://doi.org/10.1038/s41591-018-0104-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao Y, Zhang G, Jiang S, Liu YX (2024) Wekemo Bioincloud: a user-friendly platform for meta-omics data analyses. Imeta 3:e175. https://doi.org/10.1002/imt2.175

Article  PubMed  PubMed Central  Google Scholar 

Geng Y, Faber KN, de Meijer VE, Blokzijl H, Moshage H (2021) How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol Int 15:21–35. https://doi.org/10.1007/s12072-020-10121-2

Article  PubMed  Google Scholar 

Gong Z, Tas E, Yakar S, Muzumdar R (2017) Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. Mol Cell Endocrinol 455:115–130. https://doi.org/10.1016/j.mce.2016.12.022

Article  CAS  PubMed  Google Scholar 

Guo Q, Li Y, Dai X, Wang B, Zhang J, Cao H (2023) Polysaccharides: the potential Prebiotics for Metabolic Associated fatty liver Disease (MAFLD). Nutrients. https://doi.org/10.3390/nu15173722

Article  PubMed  PubMed Central  Google Scholar 

Hao P, Yang X, Yin W, Wang X, Ling Y, Zhu M, Yu Y, Chen S, Yuan Y, Quan X, Xu Z, Zhang J, Zhao W, Zhang Y, Song C, Xu Q, Qin S, Wu Y, Shu X, Wei K (2024) A study on the treatment effects of Crataegus pinnatifida polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota. Front Vet Sci 11:1383801. https://doi.org/10.3389/fvets.2024.1383801

Article  PubMed  PubMed Central  Google Scholar 

Hu YL, Ma Q, Dong X, Kong Y, Cai J, Li J, Dong C (2023) Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases. Front Nutr 10:1107551. https://doi.org/10.3389/fnut.2023.1107551

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Y, Cao J, Zhu M, Wang Z, Jin Z, Xiong Z (2024) Bacteroides fragilis aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota. Microbiol Spectr. https://doi.org/10.1128/spectrum.03393-23

Article  PubMed  PubMed Central  Google Scholar 

Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP (2020) Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities. Front Med 7:448. https://doi.org/10.3389/fmed.2020.00448

Article  Google Scholar 

James OF, Day CP (1998) Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 29:495–501. https://doi.org/10.1016/s0168-8278(98)80073-1

Article  CAS  PubMed  Google Scholar 

Jiang F, Gao H, Qin W, Song P, Wang H, Zhang J, Liu D, Wang D, Zhang T (2021) Marked seasonal variation in structure and function of gut microbiot